EPS

Expanded Medicare payment for RefleXion's SCINTIX therapy removes major financial hurdles, opening doors for advanced cancer care in community centers.

As Stryker preps its Q1 2026 report, all eyes are on whether the MedTech giant can sustain its momentum amid new products and industry-wide pressures.

Investors eye Alaska Air Group's Q1 results for insights on the Hawaiian Airlines integration, rising fuel costs, and shifting travel demand.

A new report reveals a huge gap between patient desires for holistic, less invasive fertility options and a system that defaults to costly IVF treatments.

Avory & Co. enters the crowded ETF market with AVRY, an actively managed fund shunning trends for a concentrated portfolio of high-quality stocks.

Bowhead Specialty signals a major focus on its tech-driven underwriting, scheduling key events to detail its digital growth engine ahead of its May 5th report.

The acquisition deepens Boardwalk's control of the natural gas value chain, while Spire pivots to its core utility business amid a dynamic energy market.

As Q1 results loom, the gold giant is expected to post strong figures amid high prices. Investors are watching its cash pile, costs, and hybrid AGM.

New data shows Dizal's ZEGFROVY achieved an 81.3% response rate in a lung cancer subgroup with limited options, signaling a potential new first-line standard.

Firan Technology Group sets its Q1 earnings date. With a record 2025 behind it, all eyes are on whether it can sustain growth amid industry trends.

Shareholders approve the CVB Financial and Heritage Commerce merger, forging a $22B regional bank. What does this mean for California's financial landscape?

EnerSys will unveil its strategic framework and technology roadmap, outlining its plan to navigate the energy transition and capitalize on market growth.

Keurig Dr Pepper's upcoming Q1 results are more than just numbers; they're the first look at a company on the brink of a massive transformation.

Security giant Securitas unveils a new strategy tying executive bonuses to green targets while proposing a generous dividend and share buyback plan.

As Spotify preps its Q1 2026 results, investors are watching closely. Can the audio giant sustain its growth while boosting profits amid new price hikes?

With its 32nd straight dividend hike and a $100M buyback, Wiley leverages strong Q3 results and AI momentum to underscore its financial health.

Australian giant Cobram Estate Olives acquires #1 US brand California Olive Ranch, creating a new global leader in the extra virgin olive oil market.

Lumexa Imaging posted strong 2025 revenue and cut its debt, yet a surprise net loss and EPS miss sent its stock tumbling. What's next for the imaging giant?

Adhesives giant H.B. Fuller expands margins and raises its 2026 outlook, signaling operational strength amid market softness and supply chain turmoil.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?